Pictet Asset Management (UK)’s Kite Pharma, Inc. KITE Stock Holding History

Pictet Asset Management (UK)’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-211,460	Closed	-$15.3M	–	914
2017 Q2	$15.3M	Buy	211,460 +6,575	+3%	+$537K	0.05%	401
2017 Q1	$16.1M	Sell	204,885 -82,485	-29%	-$5.1M	0.05%	391
2016 Q4	$12.9M	Buy	287,370 +23,675	+9%	+$1.16M	0.05%	396
2016 Q3	$14.7M	Buy	263,695 +80,052	+44%	+$4.46M	0.06%	370
2016 Q2	$9.41M	Buy	183,643 +168,043	+1,077%	+$8.26M	0.04%	438
2016 Q1	$698K	Hold	15,600	–	–	﹤0.01%	773
2015 Q4	$961K	Sell	15,600 -31,700	-67%	-$2.23M	﹤0.01%	786
2015 Q3	$2.63M	Sell	47,300 -40,000	-46%	-$2.52M	0.01%	675
2015 Q2	$6.35M	Sell	87,300 -7,800	-8%	-$445K	0.03%	534
2015 Q1	$4.79M	Buy	+95,100	New	+$6.37M	0.02%	592

Other funds holding KITE

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCSAM

Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Pictet Asset Management (UK)'s KITE Position: Q3 2017 in Review

Pictet Asset Management (UK) sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 211,460 shares — an estimated $15.3M sold.

Pictet Asset Management (UK) first reported a position in KITE in Q1 2015 and held it in 10 quarters. The position peaked at $16.1M in Q1 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

Pictet Asset Management (UK) reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
Pictet Asset Management (UK) sold 211,460 Kite Pharma, Inc. shares in Q3 2017, an estimated $15.3M.
Pictet Asset Management (UK) first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 10 quarters.
Pictet Asset Management (UK)'s Kite Pharma, Inc. position peaked at $16.1M in Q1 2017.
244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Pictet Asset Management (UK)'s 13F filing for Q3 2017, filed 26 Oct 2017.